Leadership update from VCHRI and Dilwari Cardiovascular Institute.
I am pleased to announce the appointment of Dr. David A. Wood as the inaugural Chief Scientific Officer of the Dilwari Cardiovascular Institute, for a five-year term to May 19, 2030.
Dr. Wood is a national and international leader in interventional and structural cardiology. He serves as head of cardiology at Vancouver General Hospital and the University of British Columbia (UBC) Hospital and is a professor in the UBC Department of Medicine. He is the founding visionary behind the Centre for Cardiovascular Innovation, a leading research enterprise advancing multi-centre clinical trials and innovation across Canada. Dr. Wood also founded Canada’s annual interventional cardiology, structural heart, and Vancouver valve meetings.
As a clinician-scientist, Dr. Wood has published extensively in high-impact journals and led landmark investigations into transcatheter valve therapies, coronary interventions and novel device strategies. In recognition of his contributions to advancing cardiovascular care worldwide, he received the Luminary Award at the C3 Global Summit.
The Dilawri Cardiovascular Institute was recently launched through a historic $60 million gift from the Dilawri Foundation to accelerate discovery, innovation and excellence in cardiovascular care. As part of Vancouver Coastal Health Research Institute (VCHRI), the Institute unites leading clinicians, researchers, scientists and trainees across disciplines to transform the prevention, diagnosis and treatment of heart disease. With world-class strengths in structural heart intervention, electrophysiology, cardiovascular imaging, augmented intelligence, translational science, women’s heart health, Indigenous cardiovascular health, pulmonary vascular disease and young adult cardiovascular care, the Institute is poised to become a global leader in cardiovascular science and innovation.
As Chief Scientific Officer, Dr. Wood will lead the Institute’s scientific vision and strategy, build research capacity, expand global partnerships and accelerate translation of discoveries into patient impact. Under his leadership, the Institute will help provide access to exceptional care for patients across British Columbia and beyond.
Please join me in congratulating Dr. Wood on this appointment and welcoming the bold chapter he and his team will lead in cardiovascular discovery, innovation and patient care in Canada and globally.
Sincerely,
Teresa S.M. Tsang, MD, FRCPC, FACC, FASE
Executive Director, VCHRI
Associate Dean, Research, UBC Faculty of Medicine
